Category Archives: Pharmaceuticals
Case Study Links Green Tea Extract in SlimQuick to Liver Injury in 24-Year-Old Woman
A case study released late last month has detailed a case of liver injury in a woman who used the SlimQuick weight loss supplement. The study, published April 27 in the World Journal of Hepatology, linked the patient’s drug induced … Continue reading
NuvaRing, Ortho Evra Pose Great Blood Clot Risk than Birth Control Pills
Using devices like NuvaRing or the Ortho Evra patch as a form of contraception presents a greater risk of serious injuries to women, namely blood clots, according to the results of a new study. BBC reports, a new study in … Continue reading
Study Finds “Robust” Risk of C. difficile with Proton Pump Inhibitors, other Heartburn Drugs
A new study has found that taking acid reducing drugs, including proton pump inhibitors, can significantly increase the risk for Clostridium difficile (C. difficile) infection. The lead author of the study, which involved a meta-analysis of 30 separate studies, characterized … Continue reading
GNC, Vitamin Shoppe Won’t Pull DMAA Supplements
Supplement giants, GNC and the Vitamin Shoppe, refuse to pull DMAA supplements, despite that the U.S. Food & Drug Administration (FDA) has issued a number of warning letters about DMAA-containing products in the past two weeks. Regardless, both GNC and … Continue reading
FDA Bisphosphonate Study Finds Few Benefits from Long-Term Use
A new U.S. Food & Drug Administration (FDA) analysis is raising serious concerns about the long-term use of bisphosphonates like Fosamax to treat weak bones. While the bisphosphonate analysis found little if any benefit from taking the drugs for more … Continue reading
Senate Committee to Explore Ties Between Prescription Painkiller Maker’s, Patient Groups
The U.S. Senate Finance Committee has opened an investigation looking for the financial ties between makers of prescription painkiller drugs, so-called pain experts, and groups designed to advise patients on proper medical care. According to a New York Times report, … Continue reading
Health Canada Updates Lexapro Label with Warning for Abnormal Heart Rhythm
Health Canada has updated the Lexapro label with a warning about the drug’s link to abnormal heart rhythm. Lexapro (escitalopram), in the family of antidepressant medications known as Selective Serotonin Reuptake Inhibitors (SSRIs), is sold in Canada as Cipralex. Lexapro, … Continue reading
Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings
Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis … Continue reading
Health Canada Issues Warning for Benlysta Hypersensitivity and Infusion Reactions
Canadian regulator, Health Canada, has just issued a warning for lupus medication, Benlysta, over hypersensitivity and infusion reactions. Benlysta (belimumab) is a prescription drug approved for the treatment of adults diagnosed with lupus (systemic lupus erythematosus or SLE), who are … Continue reading
Researcher Calls on FDA to Implement Ban on DMAA
A leading medical researcher has added to the call for a full ban on the dietary and weight loss supplement additive dimethylamylamine (DMAA). According to a Boston Globe report, a researcher at Harvard University Medical School has authored a “research … Continue reading










